HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carsten Bokemeyer Selected Research

Cetuximab (Erbitux)

10/2023Cetuximab every 2 weeks versus standard weekly dosing administration schedule.
1/2022Translational analysis and final efficacy of the AVETUX trial - Avelumab, cetuximab and FOLFOX in metastatic colorectal cancer.
1/2021Adding cetuximab to paclitaxel and carboplatin for first-line treatment of carcinoma of unknown primary (CUP): results of the Phase 2 AIO trial PACET-CUP.
1/2019Nanobody Targeting of Epidermal Growth Factor Receptor (EGFR) Ectodomain Variants Overcomes Resistance to Therapeutic EGFR Antibodies.
11/2018Clinicopathological differences and survival outcomes with first-line therapy in patients with left-sided colon cancer and rectal cancer: Pooled analysis of 2879 patients from AGITG (MAX), COIN, FOCUS2, OPUS, CRYSTAL and COIN-B trials in the ARCAD database.
1/2017Cetuximab Resistance in Head and Neck Cancer Is Mediated by EGFR-K521 Polymorphism.
7/2016Liquid biopsy monitoring uncovers acquired RAS-mediated resistance to cetuximab in a substantial proportion of patients with head and neck squamous cell carcinoma.
5/2015Epidermal growth factor receptor mutation mediates cross-resistance to panitumumab and cetuximab in gastrointestinal cancer.
10/2013Use of early tumor shrinkage to predict long-term outcome in metastatic colorectal cancer treated with cetuximab.
11/2012Functional dissection of the epidermal growth factor receptor epitopes targeted by panitumumab and cetuximab.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carsten Bokemeyer Research Topics

Disease

226Neoplasms (Cancer)
05/2024 - 03/2002
58Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
12/2023 - 05/2002
37Prostatic Neoplasms (Prostate Cancer)
12/2023 - 03/2007
31Colorectal Neoplasms (Colorectal Cancer)
11/2023 - 01/2003
29Neoplasm Metastasis (Metastasis)
12/2022 - 04/2002
26Testicular Neoplasms (Testicular Cancer)
10/2023 - 04/2002
22Seminoma
12/2023 - 04/2002
20Multiple Myeloma
03/2024 - 02/2007
15Disease Progression
07/2022 - 03/2002
15Breast Neoplasms (Breast Cancer)
06/2020 - 01/2003
14Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2022 - 12/2006
14Adenocarcinoma
02/2022 - 05/2007
13Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2024 - 04/2003
13Stomach Neoplasms (Stomach Cancer)
10/2015 - 05/2007
12Carcinoma (Carcinomatosis)
01/2021 - 05/2002
10BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
09/2021 - 01/2003
9Anemia
04/2013 - 01/2005
8Leukemia
06/2022 - 05/2005
7Ascites
08/2014 - 12/2009
6Renal Cell Carcinoma (Grawitz Tumor)
02/2024 - 01/2008
6Lung Neoplasms (Lung Cancer)
01/2024 - 01/2011
6Squamous Cell Carcinoma of Head and Neck
10/2023 - 09/2006
6Infections
12/2022 - 07/2014
6Hemorrhage
10/2022 - 01/2015
6Neutropenia
06/2019 - 07/2007
5Thrombosis (Thrombus)
02/2024 - 09/2015
5Residual Neoplasm
09/2023 - 03/2008
5Hematologic Neoplasms (Hematological Malignancy)
01/2023 - 01/2018
5Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2023 - 09/2006
5Lymphoma (Lymphomas)
01/2023 - 01/2011
5Febrile Neutropenia
01/2022 - 07/2007
5Chemotherapy-Induced Febrile Neutropenia
06/2019 - 01/2016
4Glioblastoma (Glioblastoma Multiforme)
10/2023 - 01/2012
4Pancreatic Neoplasms (Pancreatic Cancer)
01/2023 - 06/2010

Drug/Important Bio-Agent (IBA)

47Cisplatin (Platino)FDA LinkGeneric
12/2022 - 03/2002
29Proteins (Proteins, Gene)FDA Link
01/2023 - 02/2003
25Biomarkers (Surrogate Marker)IBA
01/2024 - 09/2010
19AntigensIBA
11/2023 - 09/2006
18PlatinumIBA
11/2023 - 04/2002
18AntibodiesIBA
01/2022 - 03/2009
16Cetuximab (Erbitux)FDA Link
10/2023 - 09/2008
15Fluorouracil (Carac)FDA LinkGeneric
01/2020 - 06/2004
14ErbB Receptors (EGF Receptor)IBA
01/2019 - 03/2006
13Phosphotransferases (Kinase)IBA
01/2023 - 01/2006
12Thromboplastin (Tissue Factor)IBA
04/2024 - 03/2007
12Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2020 - 01/2003
10Tumor Biomarkers (Tumor Markers)IBA
10/2023 - 05/2002
9Docetaxel (Taxotere)FDA Link
03/2023 - 05/2006
8Leucovorin (Folinic Acid)FDA Link
01/2020 - 06/2004
8Tyrosine Kinase InhibitorsIBA
12/2019 - 05/2005
8GemcitabineFDA Link
01/2019 - 04/2003
8ProteomeIBA
06/2017 - 09/2008
8Imatinib Mesylate (Gleevec)FDA Link
04/2011 - 01/2003
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2024 - 03/2006
7Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
12/2023 - 04/2002
7DNA (Deoxyribonucleic Acid)IBA
12/2023 - 10/2012
7Irinotecan (Camptosar)FDA LinkGeneric
11/2023 - 01/2003
7AlkaloidsIBA
01/2023 - 04/2012
7Paclitaxel (Taxol)FDA LinkGeneric
11/2022 - 03/2006
7Carboplatin (JM8)FDA LinkGeneric
01/2021 - 04/2003
7Hemoglobins (Hemoglobin)IBA
01/2018 - 01/2005
7catumaxomabIBA
10/2015 - 08/2010
6Bevacizumab (Avastin)FDA Link
11/2023 - 12/2009
6L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
10/2023 - 01/2013
6Member 1 Subfamily B ATP Binding Cassette TransporterIBA
03/2023 - 02/2003
6larotrectinibIBA
01/2023 - 01/2021
6Etoposide (VP 16)FDA LinkGeneric
10/2021 - 04/2003
6Trastuzumab (Herceptin)FDA Link
06/2020 - 06/2009
6Filgrastim (Neupogen)FDA Link
06/2019 - 01/2016
6Biosimilar PharmaceuticalsIBA
06/2019 - 01/2016
6AutoantibodiesIBA
04/2015 - 01/2010
5Immune Checkpoint InhibitorsIBA
01/2024 - 01/2018
5Dexamethasone (Maxidex)FDA LinkGeneric
09/2023 - 12/2006
5Messenger RNA (mRNA)IBA
01/2023 - 03/2002
5Bleomycin (Blenoxane)FDA LinkGeneric
12/2022 - 04/2008
5Cytarabine (Cytosar-U)FDA LinkGeneric
11/2022 - 01/2013
5Transcription Factors (Transcription Factor)IBA
12/2021 - 01/2013
5Dacarbazine (DIC)FDA LinkGeneric
07/2021 - 06/2008
5Protein Isoforms (Isoforms)IBA
06/2017 - 01/2006
5Epithelial Cell Adhesion MoleculeIBA
07/2014 - 08/2010
5Prostate-Specific Antigen (Semenogelase)IBA
06/2013 - 03/2007
5HematinicsIBA
04/2013 - 02/2008
4GlycosidesIBA
12/2023 - 05/2016
4TriterpenesIBA
12/2023 - 06/2010
4rhizochalininIBA
10/2023 - 10/2016
4Lenalidomide (CC 5013)FDA Link
09/2023 - 01/2010
4fibrin fragment D (D-dimer)IBA
08/2023 - 03/2007
4enzalutamideIBA
01/2023 - 10/2016
4tyrosine receptor (receptor, tyrosine)IBA
01/2023 - 12/2006

Therapy/Procedure

115Therapeutics
05/2024 - 01/2003
112Drug Therapy (Chemotherapy)
04/2024 - 04/2002
19Palliative Care (Palliative Therapy)
10/2023 - 01/2012
15Radiotherapy
12/2023 - 04/2002
12Castration
12/2023 - 06/2013
12Immunotherapy
02/2022 - 09/2006
10Combination Drug Therapy (Combination Chemotherapy)
01/2023 - 03/2006
10Salvage Therapy
01/2023 - 11/2003
9Stem Cell Transplantation
01/2022 - 02/2007
7Prostatectomy (Retropubic Prostatectomy)
01/2018 - 06/2009
5Aftercare (After-Treatment)
12/2023 - 10/2011